|
CYBRDI is the pioneer and primary provider of tissue array
products. CYBRDI has established a comprehensive and integrated
system to collect various normal and diseased human tissues, and
continuing throughout the manufacturing process of hundreds of
tissue microarrays. By offering various high-quality tissue arrays
in a format of single, paired, combined and multiple panels, CYBRDI
enables scientists to identify, verify and validate molecules of
diagnostic and therapeutic importance. Together with DNA (gene)
array technique, tissue microarray technology is a powerful tool for
the rapid analysis of molecular targets, discovery and assessment of
new therapeutics, and determining prognosis of a disease.
|
Cybrdi has developed more than 140 types of human tissue arrays
including not only common tumors, such as colon cancer, prostate
cancer, breast cancer, cervical cancer, ovarian cancer, lung cancer,
stomach cancers, esophageal cancer, rectum cancer, kidney and liver
cancer, etc., but also rare types of malignancies, e.g. brain glioma
(neuroblastoma), lymphoma, osteosarcoma, condrasarcoma (cartilage
sarcoma), bladder cancer, thyroid cancer, spongioblast tumor and
lung small cell carcinoma. We also manufacture common types of
normal multiple organs of tissue arrays.
|